Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 6/20 | 0.38 |
| ▸ | WNT1 | P04628 | 5/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.37 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.35 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.34 |
| ▸ | PARP1 | P09874 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3702436 | 0.99 | DYRK1A (0.37) | DYRK1AWNT1DPP7SIGMAR1KCNH2 | |
| SCHEMBL3703580 | 0.81 | POLB (0.42) | DYRK1AWNT1MAP4K4 | |
| Hydrochloric Acid SCHEMBL3702431 | 0.80 | POLB (0.42) | DYRK1AWNT1MAP4K4 | |
| SCHEMBL3694082 | 0.78 | MAP3K11 (0.46) | DYRK1AWNT1DPP7KCNH2MAP4K4 | |
| SCHEMBL3698706 | 0.77 | MPO (0.44) | CHEK1 | |
| SCHEMBL3694384 | 0.73 | ROCK2 (0.38) | — | |
| Hydrochloric Acid SCHEMBL3695123 | 0.72 | ROCK2 (0.38) | — | |
| SCHEMBL13604787 | 0.71 | RAB9A (0.41) | DYRK1AWNT1 | |
| SCHEMBL3703583 | 0.70 | DPP4 (0.34) | DYRK1AWNT1DPP7 | |
| Hydrochloric Acid SCHEMBL3693678 | 0.69 | ROCK2 (0.38) | DYRK1AWNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1851199-B1 | SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUNDS AS SELECTIVE 5HT2A ANTAGONISTS | AVENTIS PHARMA INC (US) | 2012-05-16 | — | — | EP | claimed |